Thierry Le Henaf
Chairman and Chief Executive Officer
Replay available
Arkema S/Adr (OTC: ARKAY) Q1 2025 earnings conference call, held 2025-05-07. Replay captured from the company's public earnings webcast.

Chairman and Chief Executive Officer
Chief Financial Officer
Analyst, Morgan Stanley
Analyst, Capital Shibboleth
Analyst, Berenberg
Analyst, Barclays
Analyst, JPMorgan
Analyst, BNP Paribas
Analyst, Adobe HF
Analyst, UBS
Analyst, Redburn Atlantic
Analyst, Bernstein
Analyst, Bank of America
Welcome to Arkema's first quarter 2025 results and outlook conference call. For your information, this call is being recorded. It will take place in a listen-only mode, and you will have the opportunity to ask questions after the presentation by pressing star N1 on your touchtone telephone. I will now hand you over to Thierry Le Henaf. Chairman and Chief Executive Officer. Sir, please go ahead. Hello, thank you very much. Good morning, everybody. So, welcome to ARCHEMAS Q1 2025 Results Conference Call. Joining me today are Marie-Josée Toncion, our CFO, and the Investor Relations Team. As always, to support this conference call, we have posted a set of slides which are available on our website. I will comment now the highlights of the quarter before letting Marie-Josée go through the financials, and at the end of the presentation, we'll be available to answer your questions as usual. After a challenging macro in 2024 during which Arkema delivered a good performance, the market environment in Q1 2025 remained difficult with volatility and also a lack of visibility, reinforced as you well know, by the ongoing uncertainty around trade tariffs that has driven certain customers, particularly in the U.S., to adopt a wait-and-see attitude. As a result, the demand went globally through across most of our markets in Europe and the U.S. in the first quarter, while Asia remains solid with significant growth. Note that there were some exceptions in the market, with well-oriented markets like electronics, which again supported PM's significant development. In this context, Arkema results end up well with EBITDA slightly down at 329 million euros for the quarter. Our specialty materials, which represent 93% of our total sales and which are the core of Arkema's strategy, showed a go...